Neoadjuvant chemotherapy for pineal region tumors - Report - MDSpire

Neoadjuvant chemotherapy for pineal region tumors

  • By

  • Christopher Troy

  • David G. Laird

  • Cameron Brimley

  • Soniya Pinto

  • Sean Himel

  • Carlos Osorno-Cruz

  • Mustafa Motiwala

  • Emal Lesha

  • Kelly Chamberlin

  • Giles Robinson

  • Amar Gajjar

  • Jason Chiang

  • Nir Shimony

  • David S. Hersh

  • Paul Klimo

  • June 3, 2026

  • 0 min

Share

Clinical Report: Preoperative Chemotherapy for Tumors in the Pineal Region

Overview

This report evaluates the impact of neoadjuvant chemotherapy on tumor volume and surgical outcomes in pediatric patients with pineal region tumors. The findings suggest that preoperative chemotherapy may enhance the feasibility of surgical resection by reducing tumor size and vascularity.

Background

Pineal region tumors are rare but significant contributors to pediatric brain tumor cases, often leading to obstructive hydrocephalus and other neurological symptoms. Their complex management requires a multidisciplinary approach, particularly due to the challenges posed by their location and histological diversity. Understanding the role of neoadjuvant chemotherapy in this context is crucial for improving surgical outcomes and patient prognosis.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • Neoadjuvant chemotherapy can reduce tumor vascularity and overall volume, potentially improving surgical outcomes.
  • Patients with pineal tumors often present with obstructive hydrocephalus, necessitating careful preoperative planning.
  • Multimodal treatment strategies are essential due to the histological heterogeneity of pineal region tumors.
  • Gross total resection (GTR) is associated with improved survival in specific tumor types without metastatic disease.
  • Endoscopic third ventriculostomy (ETV) may be utilized to manage hydrocephalus and obtain CSF for analysis.

Clinical Implications

The findings support the use of neoadjuvant chemotherapy as a strategy to facilitate safer surgical resection of pineal region tumors in pediatric patients. Clinicians should consider this approach in the context of a multidisciplinary treatment plan tailored to individual patient needs.

Conclusion

Neoadjuvant chemotherapy appears to be a promising strategy for managing pineal region tumors, potentially enhancing surgical resection outcomes. Further studies are warranted to establish standardized protocols for its use.

Related Resources & Content

  1. Patel et al., Journal of Neuro-Oncology, 2023 -- Preoperative Chemotherapy for Tumors in the Pineal Region
  2. Stereotactic radiosurgery for pineal gland metastases: results from the international radiosurgery research foundation, Journal of Neuro-Oncology, 2023
  3. Surgical Techniques for Accessing Pineal Region Tumors in the Upright Position, Journal of Neuro-Oncology, 2021
  4. Clinical Characteristics and Diagnostic Insights of Pineal Anlage Tumors: Treatment Considerations, Journal of Neuro-Oncology, 2023
  5. Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed
  6. Journal of Neuro-Oncology — Survival Rates in Patients with Gliomas of the Pineal Region Over Time
  7. EANO Guideline for intracranial germ cell tumors
  8. Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed
  9. Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children’s Oncology Group study - PMC
  10. A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors - PMC
  11. Acute toxicity of chemotherapy in central nervous system germ cell tumour patients according to age - PMC
  12. Non-germinomatous germ cell tumors of the CNS: Classification, diagnosis, and treatment - PubMed
  13. SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors - PMC
  14. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study - PMC
  15. Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data - PMC
  16. Childhood Medulloblastoma and Other CNS Embryonal Tumors (PDQ®) - NCI

Original Source(s)

Related Content